Beijing Genecradle Therapeutics Co., Ltd.
PrivateLast Round
Series A
Extension
Jun 12, 2025
Company Overview
Beijing Genecradle Therapeutics Co., Ltd. is a biotechnology company that develops gene therapy drugs and AAV vector delivery technologies for rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beijing Genecradle Therapeutics Co., Ltd. Comparables
Compare Beijing Genecradle Therapeutics Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Frontera Therapeutics | 86% | |
| Belief BioMed Inc. | 86% | |
| Exegenesis Bio | 84% | |
Beijing Genecradle Therapeutics Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jun 12, 2025 | ||||
| Series A | Dec 29, 2023 | ||||
| VC Round | Jun 1, 2023 | ||||
| Angel | Jul 7, 2022 | ||||
| Seed | Jan 5, 2022 |
Beijing Genecradle Therapeutics Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Genesis Capital | Angel |
| 深流资本 | Seed |
| Co-Win Ventures | Angel |
| Tianjin Venture Capital Management Co., Ltd. | Series A Extension |
| 华创资本 | Seed |
| Danlu Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 29, 2023
Raised Series A round led by Danlu Capital.
- Jun 1, 2023
$14M raised in a VC Round.
Beijing Genecradle Therapeutics Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Beijing Genecradle Therapeutics Co., Ltd.'s valuation, stock price, and market status.